Criteria Bio Ventures

Adaptam Therapeutics develops antibody-based cancer immunotherapies, including antibody-drug conjugates and bispecific antibodies, that target the immunosuppressive myeloid tumor microenvironment via novel targets such as glycan-binding proteins and Siglecs.

BiotechHealthtechSan Sebastián, ES

Asis Palazon(CEO/CSO & Founder)in

AELIX Therapeutics is a company developing a therapeutic HIV vaccine intended for use in HIV cure and eradication strategies.

BiotechHealthtechBarcelona, ES

Co-investorsYsios Capital

aptaTargets is a clinical-stage biopharmaceutical company developing therapeutic aptamers for acute indications where inflammation causes damage, such as ischemic stroke, intracerebral hemorrhage, myocardial infarction, and multiple sclerosis.

BiotechHealthtechMadrid, ES

CIRCE Scientific develops patented ingredient synergies and formulations focused on cellular and systemic resilience, working with clients to co-create products for supplements, functional foods, cosmetics, and animal care.

BiotechLongevityWellness & Fitness

Development of point-of-care diagnostic testing systems.

Biopharmaceutical focused on developing therapeutic aptamers.

Predicting bone metastasis to improve cancer patients' quality of life.

Experimental screenings to find new polymorphs and co-crystals of active pharmaceutical ingredients.

Unlocking intra-cellular drug targets.

Novel in vitro diagnostic biomarker for the early detection of cardiac ischemia.

Next-generation immune cell engagers for cancer.

A novel mitochondrial-targeted therapy for neurodegenerative diseases.

Safer and more effective treatments for cancer patients.

Thymus-based therapies for immune-mediated diseases.

Cytospire Therapeutics develops multispecific antibodies and next-generation γδ T cell engagers designed to direct innate and adaptive immune effector cells as an alternative to CD3-based engagers.

BiotechHealthtech

Co-investorsLifeArc VenturesMedical Incubator Japan K.K.Modi VenturesPathway BioventuresSound Bioventures

Devicare sells nutritional and health products, including supplements and monitoring devices for conditions such as kidney stones and urinary infections.

ConsumerHealthtechWellness & Fitness

Co-investorsCapital CellEmesa Corporación EmpresarialShip2B

Inbiomotion develops the MAF Test, a biomarker diagnostic based on MAF gene expression that helps doctors select early breast cancer patients for adjuvant bisphosphonate treatment.

BiotechDigital HealthMedical Devices

Co-investorsYsios CapitalAlta Life SciencesAsabys Partners

Clinical-stage biotech developing therapies for orphan CNS diseases; lead program MIN-102 in trials for X-linked Adrenoleukodystrophy and Friedreich's Ataxia.

Co-investorsFund+

Minoryx is a biopharmaceutical company that discovers and develops drug treatments for severe orphan diseases of the central nervous system, such as cerebral adrenoleukodystrophy and Rett syndrome.

BiotechHealthtech

Co-investorsChiesi VenturesFund+Invivo Capital PartnersKurma PartnersRoche Venture FundYsios Capital+1 more

Oncology-focused company whose clinical assets moved to Boehringer Ingelheim and AstraZeneca.

Clinical assets for cancer treatment.

NRG Therapeutics is a clinical-stage neuroscience drug discovery company developing disease-modifying, oral small-molecule medicines that target mitochondrial function via inhibition of the mitochondrial permeability transition pore.

BiotechHealthtechLongevity

Co-investorsM VenturesNovartis Venture FundSV Health InvestorsBritish Business BankDementia Discovery Fund

Nuubo offers a wireless, non-invasive cardiac monitoring technology (aECG) based on textile electrodes for medium- and long-term remote heart monitoring.

Digital HealthHardwareMedical Devices

Co-investorsCapital CellFides Capital

CSL is a biotechnology company that develops and manufactures plasma-derived and other therapies, including biotherapies for rare and serious diseases, vaccines, and treatments for iron deficiency and kidney disease.

BiotechHealthtechMedical Devices

Joan Perello Bestard(Founder)inCris Calsadain

Co-investorsAndera PartnersInvivo Capital PartnersYsios Capital

SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.

BiotechDeep TechDigital HealthBarcelona, ES

Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)

Co-investorsNovartis Venture FundRoche Venture FundSanofi VenturesYsios CapitalAsabys PartnersNew Enterprise Associates (NEA)+2 more

Tolerance is a compliance platform that runs continuous automated checks against the NIST 800-171 standard and collects assessor-ready evidence for teams handling Controlled Unclassified Information (CUI).

CybersecurityGovTechSaaS

Co-investorsDorm RoomAmadeus Capital PartnersBen Franklin Technology PartnersBioAdvanceColumbus Venture PartnersEast Innovate+4 more

BiotechPhiladelphia, US

Francisco Leon(Executive Officer, Director)Philip Ball(Executive Officer, Director)Justin Vogel(Executive Officer, Director)

BoardDamia Tormo Carulla(Director)Pablo Cironi(Director)inRobert Goldstein(Director)

Co-investorsBioAdvance

Co-investorsBullnet Gestión SGECR, S. A.Criteria Venture TechIntel CapitalTEL Venture Capital, Inc.